Senior Director leading access evidence generation strategy for oncology pipeline assets at Pfizer. Collaborating with cross-functional teams for optimal patient access and market strategies.
Responsibilities
Lead the development of access evidence generation strategy to support the value of Pfizer’s Oncology pipeline assets, in close partnership with the cross-functional matrix team
Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the access evidence strategy to support global market access needs at launch and through lifecycle
Lead the timely development of early launch deliverables including early global value dossiers, value and evidence strategy, integrated evidence plan, systematic literature reviews, early economic models, predictive analytics for value and evidence, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries
Lead the design and execution of global HEOR studies (e.g., network meta-analyses, real-world evidence) from concept through publication
Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements
Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers
Identify opportunities to partner with external stakeholders to conduct Value and Evidence projects in support of the oncology pipeline assets
Partner with other GAV cross functional colleagues to ensure strategic alignment and successful/timely execution of projects
Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies
Requirements
Doctorate degree (e.g. PhD, PharmD, DrPH) and 7+ years of experience in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
Graduate degree (e.g. MPH, MSc) and 10+ years of experience in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
Demonstrated in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation
Capable of independently managing complex non-interventional study projects
Knowledge and understanding of drug development process is strongly preferred
Knowledge and experience in the oncology therapeutic area is preferred
Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups is desirable
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
Excellent oral and written English communication skills required
Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
Director of Integrations leading integration practice and managing high - performing team at Sol de Janeiro. Overseeing operational excellence and seamless data flow in a fast - growing beauty brand.
Director of Supplier Resiliency leading global Supplier Resiliency and Supply Chain Risk Management at HARMAN. Responsible for ensuring robustness, continuity, and sustainability of automotive supply base.
Director of Portfolio Management at Rexford Industrial responsible for managing day - to - day activities of properties and property staff. Leading strategies to enhance commercial industrial real estate portfolio results.
Director of Compensation at SelectQuote responsible for compensation program strategy and administration. Leading compensation analytics and ensuring competitive market positioning.
Director of Engagement leading strategy for C.A. Fortune's top client partnerships in the CPG industry. Focusing on strategic initiatives, KPI management, and client relationship oversight.
Associate Director managing integration and separation projects, ensuring successful delivery within budget and timeline. Play a key role in the Value Creation team at Interpath.
Directeur général supervisant le développement d'une ligue de rugby régionale à Saint - Herblain, France. Responsable de l'exécution des décisions stratégiques et du management des équipes.
Directeur(trice) de magasin chez Lunettes Pour Tous à Paris. Gérer une équipe, atteindre des objectifs de chiffre d'affaires et garantir une expérience client exceptionnelle.
Director of Individual Solutions Technology in a financial services company. Leading technology strategies for distribution and product lifecycle to enhance customer and partner experiences.
Director of Participant Strategy & Engagement at Richmond Pharmacology, overseeing strategic operations and participant engagement in clinical studies. Driving collaboration and compliance for successful recruitment targets.